Ole Andreas Halvorsen
Viking Global Investors
Ole Andreas Halvorsen RayzeBio, Inc stake
total: 670
Viking Global Investors RYZB trades
- Total transactions:
- 2
- New positions:
- 1
- Sold out:
- 1
- Held since:
- 2023 Q3
- Held for:
- 2 quarters
- Latest activity:
- 2024 Q1
According to 2026 Q2 report, Ole Andreas Halvorsen doesn't hold any RayzeBio, Inc (RYZB) shares. To date, the estimated cost basis is nearly $22.2 for "buy" trades and estimated average "sell" price is $62.17. Viking Global Investors first purchased RYZB in 2023 Q3, initially acquiring about 6.64M shares. Since the initial investment in RayzeBio, Inc (RYZB), Viking Global Investors has made 1 more transaction.
When did Ole Andreas Halvorsen sell RayzeBio, Inc (RYZB)?
Ole Andreas Halvorsen sold off the entire RayzeBio, Inc (RYZB) position in 2024 Q1.
When did Ole Andreas Halvorsen buy RayzeBio, Inc (RYZB)?
Ole Andreas Halvorsen first invested in RayzeBio, Inc (RYZB) in 2023 Q3 at the reported quarter-end price of $22.20 per share.
What's the cost basis of Viking Global Investors's RYZB stake?
The estimated cost basis for RayzeBio, Inc (RYZB) stake is around $22.20 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $22.20
- Weighted AVG sell price:
- $62.17
Ole Andreas Halvorsen's historical trades in RayzeBio, Inc
2 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2024 Q1
|
0.00%
|
0
|
$62.17
|
|
-100% (-6,642,700)
|
-1.51%
|
|
2023 Q3
|
0.60%
|
6,642,700
|
$22.20
|
$147,467,940
|
new
|
+0.6%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.